![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1552653 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of MAST4 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MAST4 mRNA | CTD | PMID:26496021 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAST4 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MAST4 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1601915 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAST4 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:1601915 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of MAST4 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAST4 mRNA | CTD | PMID:28628672, PMID:31601247 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1552653 | 6480464 | Fenretinide results in increased expression of MAST4 mRNA | CTD | PMID:28973697 | 5-fluorouracil | increases expression | ISO | RGD:1601915 | 6480464 | Fluorouracil results in increased expression of MAST4 mRNA | CTD | PMID:16510598 | aflatoxin B1 | increases expression | ISO | RGD:1601915 | 6480464 | Aflatoxin B1 results in increased expression of MAST4 mRNA | CTD | PMID:21641981 | aflatoxin B1 | decreases methylation | ISO | RGD:1601915 | 6480464 | Aflatoxin B1 results in decreased methylation of MAST4 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | RGD:1601915 | 6480464 | Tretinoin results in increased expression of MAST4 mRNA | CTD | PMID:21934132, PMID:23830798 | antirheumatic drug | increases expression | ISO | RGD:1601915 | 6480464 | Antirheumatic Agents results in increased expression of MAST4 mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | RGD:1601915 | 6480464 | Arsenic affects the methylation of MAST4 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1601915 | 6480464 | Arsenic affects the methylation of MAST4 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | RGD:1601915 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to MAST4 mRNA] | CTD | PMID:32406909 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of MAST4 mRNA | CTD | PMID:36841081 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of MAST4 gene | CTD | PMID:35440735 | benzo[a]pyrene | affects methylation | ISO | RGD:1552653 | 6480464 | Benzo(a)pyrene affects the methylation of MAST4 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1601915 | 6480464 | Benzo(a)pyrene results in increased expression of MAST4 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | RGD:1601915 | 6480464 | Benzo(a)pyrene affects the methylation of MAST4 promoter | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | ISO | RGD:1601915 | 6480464 | benzo(e)pyrene results in increased methylation of MAST4 intron | CTD | PMID:30157460 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MAST4 mRNA | CTD | PMID:26496021 | bisphenol A | affects methylation | ISO | RGD:1601915 | 6480464 | bisphenol A affects the methylation of MAST4 gene | CTD | PMID:31601247 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MAST4 mRNA | CTD | PMID:25181051, PMID:30816183 | bisphenol F | multiple interactions | ISO | RGD:1601915 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of MAST4 gene | CTD | PMID:31601247 | butanal | decreases expression | ISO | RGD:1601915 | 6480464 | butyraldehyde results in decreased expression of MAST4 mRNA | CTD | PMID:26079696 | cadmium dichloride | increases expression | ISO | RGD:1601915 | 6480464 | Cadmium Chloride results in increased expression of MAST4 mRNA | CTD | PMID:12160620 | caffeine | decreases phosphorylation | ISO | RGD:1601915 | 6480464 | Caffeine results in decreased phosphorylation of MAST4 protein | CTD | PMID:35688186 | calcitriol | decreases expression | ISO | RGD:1601915 | 6480464 | Calcitriol results in decreased expression of MAST4 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | RGD:1601915 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of MAST4 mRNA | CTD | PMID:21592394 | CGP 52608 | multiple interactions | ISO | RGD:1601915 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MAST4 gene] | CTD | PMID:28238834 | cisplatin | increases expression | ISO | RGD:1601915 | 6480464 | Cisplatin results in increased expression of MAST4 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | RGD:1601915 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MAST4 mRNA | CTD | PMID:27392435 | clobetasol | decreases expression | ISO | RGD:1552653 | 6480464 | Clobetasol results in decreased expression of MAST4 mRNA | CTD | PMID:27462272 | copper(II) sulfate | increases expression | ISO | RGD:1601915 | 6480464 | Copper Sulfate results in increased expression of MAST4 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | RGD:1601915 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA | CTD | PMID:19167446 | crocidolite asbestos | decreases expression | ISO | RGD:1601915 | 6480464 | Asbestos, Crocidolite results in decreased expression of MAST4 mRNA | CTD | PMID:25351596 | crocidolite asbestos | decreases expression | ISO | RGD:1552653 | 6480464 | Asbestos, Crocidolite results in decreased expression of MAST4 mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | RGD:1601915 | 6480464 | Cyclosporine results in decreased expression of MAST4 mRNA | CTD | PMID:25562108, PMID:27989131 | dexamethasone | increases expression | ISO | RGD:1601915 | 6480464 | Dexamethasone results in increased expression of MAST4 mRNA | CTD | PMID:25047013 | dexamethasone | multiple interactions | ISO | RGD:1601915 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAST4 mRNA | CTD | PMID:28628672 | dibutyl phthalate | increases expression | ISO | RGD:1552653 | 6480464 | Dibutyl Phthalate results in increased expression of MAST4 mRNA | CTD | PMID:21266533 | dicrotophos | increases expression | ISO | RGD:1601915 | 6480464 | dicrotophos results in increased expression of MAST4 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | RGD:1601915 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Enterolactone | multiple interactions | ISO | RGD:1601915 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA | CTD | PMID:19167446 | epoxiconazole | increases expression | ISO | RGD:1552653 | 6480464 | epoxiconazole results in increased expression of MAST4 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | ISO | RGD:1552653 | 6480464 | Ethanol affects the splicing of MAST4 mRNA | CTD | PMID:30319688 | fluoranthene | multiple interactions | ISO | RGD:1552653 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of MAST4 mRNA | CTD | PMID:28329830 | folic acid | decreases expression | ISO | RGD:1552653 | 6480464 | Folic Acid results in decreased expression of MAST4 mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | RGD:1601915 | 6480464 | Formaldehyde results in decreased expression of MAST4 mRNA | CTD | PMID:20655997 | fulvestrant | increases methylation | ISO | RGD:1601915 | 6480464 | Fulvestrant results in increased methylation of MAST4 gene | CTD | PMID:31601247 | fulvestrant | multiple interactions | ISO | RGD:1601915 | 6480464 | [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of MAST4 gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of MAST4 gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MAST4 mRNA | CTD | PMID:22061828 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MAST4 mRNA | CTD | PMID:33387578 | glyphosate | increases expression | ISO | RGD:1552653 | 6480464 | glyphosate results in increased expression of MAST4 mRNA | CTD | PMID:35897073 | hydrogen peroxide | multiple interactions | ISO | RGD:1552653 | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | indometacin | multiple interactions | ISO | RGD:1601915 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAST4 mRNA | CTD | PMID:28628672 | lead(0) | affects expression | ISO | RGD:1601915 | 6480464 | Lead affects the expression of MAST4 mRNA | CTD | PMID:28903495 | mercury dibromide | increases expression | ISO | RGD:1601915 | 6480464 | mercuric bromide results in increased expression of MAST4 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | RGD:1601915 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAST4 mRNA | CTD | PMID:27188386 | methapyrilene | increases methylation | ISO | RGD:1601915 | 6480464 | Methapyrilene results in increased methylation of MAST4 intron | CTD | PMID:30157460 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of MAST4 gene | CTD | PMID:35440735 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of MAST4 mRNA | CTD | PMID:33484710 | paracetamol | affects expression | ISO | RGD:1552653 | 6480464 | Acetaminophen affects the expression of MAST4 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MAST4 mRNA | CTD | PMID:33387578 | phenylmercury acetate | increases expression | ISO | RGD:1601915 | 6480464 | Phenylmercuric Acetate results in increased expression of MAST4 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1601915 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAST4 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | RGD:1552653 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MAST4 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:1552653 | 6480464 | pirinixic acid results in increased expression of MAST4 mRNA | CTD | PMID:20813756 | SB 431542 | multiple interactions | ISO | RGD:1601915 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | RGD:1601915 | 6480464 | Silicon Dioxide analog results in decreased expression of MAST4 mRNA | CTD | PMID:25895662 | silicon dioxide | increases expression | ISO | RGD:1601915 | 6480464 | Silicon Dioxide results in increased expression of MAST4 mRNA | CTD | PMID:25351596 | sodium arsenite | affects methylation | ISO | RGD:1601915 | 6480464 | sodium arsenite affects the methylation of MAST4 gene | CTD | PMID:28589171 | sodium fluoride | decreases expression | ISO | RGD:1552653 | 6480464 | Sodium Fluoride results in decreased expression of MAST4 mRNA | CTD | PMID:27862939 | sotorasib | multiple interactions | ISO | RGD:1601915 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAST4 mRNA | CTD | PMID:36139627 | testosterone | multiple interactions | ISO | RGD:1601915 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of MAST4 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | RGD:1601915 | 6480464 | Testosterone results in decreased expression of MAST4 mRNA | CTD | PMID:21592394 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MAST4 mRNA | CTD | PMID:34492290 | trametinib | multiple interactions | ISO | RGD:1601915 | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAST4 mRNA | CTD | PMID:36139627 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of MAST4 mRNA | CTD | PMID:33387578 | triptonide | decreases expression | ISO | RGD:1552653 | 6480464 | triptonide results in decreased expression of MAST4 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | RGD:1552653 | 6480464 | Tungsten results in decreased expression of MAST4 mRNA | CTD | PMID:30912803 | tunicamycin | increases expression | ISO | RGD:1552653 | 6480464 | Tunicamycin results in increased expression of MAST4 mRNA | CTD | PMID:17127020 | valproic acid | decreases expression | ISO | RGD:1601915 | 6480464 | Valproic Acid results in decreased expression of MAST4 mRNA | CTD | PMID:29154799 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MAST4 mRNA | CTD | PMID:29427782 | valproic acid | multiple interactions | ISO | RGD:1601915 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAST4 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:1601915 | 6480464 | Valproic Acid results in increased expression of MAST4 mRNA | CTD | PMID:23179753 more ... | vancomycin | decreases expression | ISO | RGD:1552653 | 6480464 | Vancomycin results in decreased expression of MAST4 mRNA | CTD | PMID:18930951 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of MAST4 mRNA | CTD | PMID:23034163 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of MAST4 mRNA | CTD | PMID:19015723 | vitamin E | decreases expression | ISO | RGD:1601915 | 6480464 | Vitamin E results in decreased expression of MAST4 mRNA | CTD | PMID:19244175 | zoledronic acid | increases expression | ISO | RGD:1601915 | 6480464 | zoledronic acid results in increased expression of MAST4 mRNA | CTD | PMID:24714768 | |